NCT06727812View on ClinicalTrials.gov

Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

206

Participants

Timeline

Start Date

December 27, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions

Solid Tumors

Interventions

DRUG

HRS-6208

HRS-6208.

Trial Locations (1)

610041

RECRUITING

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY